Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
•
General Internal Medicine
•
Pulmonology
When a patient presents with 2 lung lesions, do you routinely recommend a biopsy of both lung lesions?
Would your practice change if the patient had N2 disease?
Answer from: Radiation Oncologist at Academic Institution
2nd lesion may be a satellite met.
Comments
Radiation Oncologist at Mon Health
Or different histology, or even benign.
3420
Sign in or Register to read more
6703
Related Questions
What is your approach to radiographically suspicious lung nodules for which initial biopsy was negative for malignancy?
Do you perform EBUS-TBNA for staging in patients with biopsy proven malignant lung nodules with no lymphadenopathy on CT chest and PET scan?
Is there increased risk with lung SBRT in a patient who has a mild asymptomatic pneumothorax in the field after CT-guided needle biopsy?
How well does a negative non-contrast MRI of the brain exclude metastasis in a patient with squamous cell carcinoma of the lung?
Would you offer lung SBRT in a patient with Pulmonary Langerhans Cell Histiocytosis (PLCH)?
Would a metal endobronchial stent within the treatment field change your radiation treatment plan for a thoracic malignancy?
Can palliative radiation be used to treat recurrent malignant pleural effusion in NSCLC?
What is your planning approach for SBRT when the tumor abuts the great vessels such as aortic arch or SVC?
How would you approach an in-field recurrence after lung SBRT for a T1 NSCLC in a patient with poor underlying lung function?
In stage IV oligometastatic NSCLC, when considering local consolidative therapies to the primary tumor, do providers typically stage the mediastinum at diagnosis or after initial systemic therapy (assuming no progression)?
Or different histology, or even benign.